IP Library Assignment 074729/0205
Patent Assignment
Reel/Frame 074729/0205

Release of Security Interest

Recorded: 2026-05-21 Pages: 13
Assignor
Assignees
AVADEL CNS PHARMACEUTICALS, LLC
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN, D04 C5Y6, IRELAND
FLAMEL IRELAND LTD.
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN, D04 C5Y6, IRELAND
Covered Properties (41)
Methods of Administering Gamma-Hydroxybutyrate Compositions with Divalproex Sodium
Application: 63/010,974 →
Gamma-Hydroxybutyrate Compositions Having Improved Pharmacokinetics in the Fed State
Application: 62/812,699 →
Gamma-Hydroxybutyrate Compositions Having Improved Pharmacokinetics in the Fed State
Application: 62/857,008 →
Gamma-Hydroxybutyrate Compositions Having Improved Pharmacokinetics in the Fed State
Application: 16/987,515 →
Publication: US 2020/0368187
Gamma-Hydroxybutyrate Compositions Having Improved Pharmacokinetics in the Fed State
Application: 17/837,740 →
Publication: US 2022/0313635
Methods of Administering Gamma-Hydroxybutyrate Compositions with Divalproex Sodium
Application: 17/231,455 →
Publication: US 2021/0322348
Methods of Administering Gamma-Hydroxybutyrate Compositions with Divalproex Sodium
Application: 17/896,483 →
Publication: US 2022/0409561
Methods of Administering Gamma-Hydroxybutyrate Compositions with Divalproex Sodium
Application: 17/502,562 →
Publication: US 2022/0040128
Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 17/322,299 →
Publication: US 2021/0267928
Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 17/194,780 →
Publication: US 2021/0186916
Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 17/530,096 →
Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 17/178,117 →
Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 17/484,916 →
Publication: US 2022/0016066
Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 18/075,980 →
Publication: US 2023/0172892
Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 18/096,508 →
Publication: US 2023/0172893
Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 18/120,231 →
Publication: US 2023/0210804
Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 17/966,538 →
Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 63/255,755 →
Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 17/731,562 →
Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 17/666,201 →
Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 18/141,666 →
Nightly Dose Packet Storage Set
Patent: 1,032,378 →
Application: 29/770,898 →
Nightly Dose Packet Storage System
Patent: 1,051,587 →
Application: 29/827,076 →
Packaged Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Stability
Application: 62/607,937 →
Packaged Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Stability
Application: 62/618,832 →
Packaged Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Stability
Application: 16/223,940 →
Publication: US 2019/0183806
Packaged Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Stability
Application: 17/156,053 →
Publication: US 2021/0137843
Packaged Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Stability
Application: 16/984,645 →
Publication: US 2020/0360293
Gamma-Hydroxybutyrate Compositions Having Improved Pharmacokinetics in the Fed State
Application: 16/804,966 →
Publication: US 2020/0276142
Gamma-Hydroxybutyrate Compositions Having Improved Pharmacokinetics in the Fed State
Application: 16/987,510 →
Publication: US 2020/0360319
Methods of Administering Gamma Hydroxybutyrate Formulations After a High-Fat Meal
Application: 17/666,205 →
Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 15/655,924 →
Publication: US 2018/0021284
Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 16/281,235 →
Publication: US 2019/0183836
Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 16/420,321 →
Publication: US 2019/0274990
Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 16/527,633 →
Publication: US 2020/0197347
Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 17/497,366 →
Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 17/497,381 →
Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 17/497,393 →
Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 16/419,516 →
Publication: US 2019/0269640
Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 16/419,616 →
Publication: US 2019/0269641
Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Application: 16/431,219 →
Publication: US 2019/0282532
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 8, 2019
From: GUILLARD, HERVÉ
To: FLAMEL IRELAND LIMITED
Reel/Frame 047925/0714 →
Assignment of Assignor's Interest Mar 13, 2019
From: GRANGEON, CENDRINE; GRASSOT, JULIEN
To: FLAMEL IRELAND LIMITED
Reel/Frame 048588/0040 →
Assignment of Assignor's Interest Jun 28, 2019
From: GRASSOT, JULIEN; GRANGEON, CENDRINE
To: FLAMEL IRELAND LIMITED
Reel/Frame 049625/0693 →
Assignment of Assignor's Interest Aug 5, 2020
From: GRASSOT, JULIEN
To: FLAMEL IRELAND LIMITED
Reel/Frame 053413/0630 →
Assignment of Assignor's Interest Aug 11, 2020
From: GRASSOT, JULIEN; DUBOW, JORDAN; GRANGEON, CENDRINE
To: FLAMEL IRELAND LIMITED
Reel/Frame 053463/0309 →
Assignment of Assignor's Interest Feb 18, 2021
From: MÉGRET, CLAIRE; GUILLARD, HERVÉ; DUBUISSON, JEAN-FRANÇOIS
To: FLAMEL IRELAND LIMITED
Reel/Frame 055317/0664 →
Assignment of Assignor's Interest Mar 9, 2021
From: MÉGRET, CLAIRE; GUILLARD, HERVÉ; DUBUISSON, JEAN-FRANÇOIS
To: FLAMEL IRELAND LIMITED
Reel/Frame 055536/0537 →
Assignment of Assignor's Interest Jun 29, 2021
From: GRASSOT, JULIEN
To: FLAMEL IRELAND LIMITED
Reel/Frame 056707/0780 →
Assignment of Assignor's Interest Sep 8, 2021
From: SCHAEFER, WILLIAM; REID, JENNY; KRUCHOWSKI, HEATHER
To: FLAMEL IRELAND LIMITED
Reel/Frame 057417/0179 →
Assignment of Assignor's Interest Sep 27, 2021
From: MÉGRET, CLAIRE; GUILLARD, HERVÉ; DUBUISSON, JEAN-FRANÇOIS
To: FLAMEL IRELAND LIMITED
Reel/Frame 057607/0391 →
Assignment of Assignor's Interest Dec 2, 2021
From: GRASSOT, JULIEN
To: FLAMEL IRELAND LIMITED
Reel/Frame 058271/0036 →
Assignment of Assignor's Interest Dec 2, 2021
From: MÉGRET, CLAIRE; GUILLARD, HERVÉ; DUBUISSON, JEAN-FRANÇOIS
To: FLAMEL IRELAND LIMITED
Reel/Frame 058270/0932 →
Assignment of Assignor's Interest Jun 17, 2022
From: DUBOW, JORDAN
To: FLAMEL IRELAND LIMITED
Reel/Frame 060237/0228 →
Assignment of Assignor's Interest Jun 17, 2022
From: DUBOW, JORDAN; GRANGEON, CENDRINE; GUILLARD, HERVÉ; MÉGRET, CLAIRE
To: FLAMEL IRELAND LIMITED
Reel/Frame 060237/0146 →
Assignment of Assignor's Interest Aug 24, 2022
From: SCHAEFER, WILLIAM J.; REID, JENNY; KRUCHOWSKI, HEATHER
To: FLAMEL IRELAND LIMITED
Reel/Frame 060891/0492 →
Assignment of Assignor's Interest Aug 28, 2022
From: GRASSOT, JULIEN; MONTEITH, DAVID; GUILLARD, HERVÉ; MÉGRET, CLAIRE
To: FLAMEL IRELAND LIMITED
Reel/Frame 060920/0289 →
Assignment of Assignor's Interest Sep 15, 2022
From: GRASSOT, JULIEN; GRANGEON, CENDRINE; DUBOW, JORDAN
To: FLAMEL IRELAND LIMITED
Reel/Frame 061106/0165 →
Assignment of Assignor's Interest Oct 26, 2022
From: GRASSOT, JULIEN
To: FLAMEL IRELAND LIMITED
Reel/Frame 061539/0694 →
Assignment of Assignor's Interest Feb 6, 2023
From: DUBOW, JORDAN; GUILLARD, HERVÉ; MÉGRET, CLAIRE; DUBUISSON, JEAN-FRANÇOIS
To: FLAMEL IRELAND LIMITED
Reel/Frame 062597/0899 →
Assignment of Assignor's Interest Mar 2, 2023
From: DUBOW, JORDAN; MÉGRET, CLAIRE; GUILLARD, HERVÉ; DUBUISSON, JEAN-FRANÇOIS
To: FLAMEL IRELAND LIMITED
Reel/Frame 062858/0001 →
Assignment of Assignor's Interest Mar 13, 2023
From: DUBOW, JORDAN; GUILLARD, HERVÉ; MÉGRET, CLAIRE; DUBUISSON, JEAN-FRANÇOIS
To: FLAMEL IRELAND LIMITED
Reel/Frame 062966/0630 →
Assignment of Assignor's Interest May 10, 2023
From: DUBOW, JORDAN; GUILLARD, HERVÉ; MÉGRET, CLAIRE; DUBUISSON, JEAN-FRANÇOIS
To: FLAMEL IRELAND LIMITED
Reel/Frame 063593/0573 →
Patent Collateral Agreement Aug 1, 2023
From: AVADEL CNS PHARMACEUTICALS, LLC; FLAMEL IRELAND LTD.
To: RTW INVESTMENTS, LP
Reel/Frame 064463/0907 →
Assignment of Assignor's Interest Sep 23, 2025
From: DUBOW, JORDAN; GRANGEON, CENDRINE; GUILLARD, HERVÉ; MÉGRET, CLAIRE
To: FLAMEL IRELAND LIMITED
Reel/Frame 072344/0050 →